Temporal pattern discovery in longitudinal electronic patient records

Data Mining and Knowledge Discovery

Volumn 20, Issue 3, 2010, Pages 361-387

  Norén, G Niklas ^a,b   Hopstadius, Johan ^a   Bate, Andrew ^a,c   Star, Kristina ^a   Edwards, I Ralph ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Electronic health records; Longitudinal patient records; Temporal pattern discovery

Indexed keywords

COMPUTER APPLICATIONS; DATA MINING;

ELECTRONIC HEALTH RECORD; ELECTRONIC PATIENT RECORD; EXPLORATORY DATA ANALYSIS; PATIENT RECORD; STATISTICAL APPROACH; TEMPORAL ASSOCIATION; TEMPORAL PATTERN DISCOVERY; TEMPORAL RELATIONSHIPS;

MEDICAL COMPUTING;

EID: 81355127388     PISSN: 13845810     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10618-009-0152-3     Document Type: Article

References (18)

1. Agrawal R, Srikant R (1995) Mining sequential patterns. In: Yu PS, Chen ASP (eds) Eleventh international conference on data engineering. IEEE Computer Society Press, Taipei, pp 3-14
2. Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM (1998) A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 54:315-321
3. Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R (2007) Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 16(12):1275-1284
4. DuMouchel W (1999) Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 53:177-202
5. Farrington CP (1995) Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 51(1):228-235
6. Han J, Cheng H, Xin D, Yan X (2007) Frequent pattern mining: current status and future directions. Data Min Knowl Discov 15(1):55-86
7. Hocine MN, Musonda P, Andrews NJ, Farrington CP (2009) Sequential case series analysis for pharmacovigilance. J R Stat Soc A Stat Soc 172(1):213-236
8. Hopstadius J, Norén GN, Bate A, Edwards IR (2008) Adjustment for potential confounders in adverse drug reaction surveillance. Drug Saf 31(11):1035-1048
9. Jin H, Chen J, He H, Williams GJ, Kelman C, O'Keefe CM (2008) Mining unexpected temporal associations: applications in detecting adverse drug reactions. IEEE Trans Inf Technol Biomed 12(4):488-500]
10. Keim DA, Schneidewind J (2007) Introduction to the special issue on visual analytics. SIGKDD Explor 9(2):3-4
11. Lindquist M, Stahl M, Bate A, Edwards IR, Meyboom RHB (2000) A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in theWHO international database. Drug Saf 23(6):533-542
12. Mannila H, Toivonen H, Verkamo AI (1997) Discovery of frequent episodes in event sequences. Data Min Knowl Discov 1(3):259-289
13. Norén GN, Bate A, Orre R, Edwards IR (2006) Extending the methods used to screen theWHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med 25(21):3740-3757
14. Norén GN, Orre R, Bate A, Edwards IR (2007) Duplicate detection in adverse drug reaction surveillance. Data Min Knowl Discov 14(3):305-328
15. Norén GN, Bate A, Hopstadius J, Star K, Edwards IR (2008a) Temporal pattern discovery for trends and transient effects: its application to patient records. In: Proceedings of the fourteenth ACM SIGKDD international conference on knowledge discovery and data mining (KDD'08). ACM Press, New York, pp 963-971
16. Norén GN, Sundberg R, Bate A, Edwards IR (2008) A statistical methodology for drug-drug interaction surveillance. Stat Med 27(16):3057-3070
17. Pirmohamed M, James S, Meakin S, Green C, Scott A, Walley T, Farrar K, Park B, Breckenridge A (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 329:15-19
18. Wadman M (2007) Experts call for active surveillance of drug safety. Nature 446:358-359